Latest filing published 20 Nov 2017 for X4 Pharmaceuticals, Inc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -92.3%Entry US$2,773.80 · Close at T+365 US$214.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
EMBL Technology Fund II GmbH & Co. KG: trading record in brief
EMBL Technology Fund II GmbH & Co. KG appears in our data through filings on X4 Pharmaceuticals, Inc shares, published by SEC (Form 4). Altogether 3 filings, all relating to 20 November 2017.
No open-market sale appears; the market trades are 1 purchase worth €170k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 20 November 2017: a transaction, in X4 Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 3,276 days ago, on 20 November 2017. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to EMBL Technology Fund II GmbH & Co. KG
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 103,278 sharesCommon StockSEC:0000899243-17-027103:0
- 247,176 sharesCommon StockSEC:0000899243-17-027103:1
- 20,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-17-027103:2Canonical exit: 18 Feb 2018 (T+90)
3 of 3 declarations
